2.4 semaglutide to tirzepatide Early Dose Escalation of after Switching from in Type 2 Diabetes Mellitus How to Switch from Tirzepatide

Do not adjust dosing or add additional compounds during this period

GLP-1 receptor agonists have become a paradigm shift in treating the two conditions together, and clinical trials have shown an average of 15-22% body weight loss with recent preparations (semaglutide and tirzepatide)

Tirzepatide is making strides as a significant player in weight management, especially for those dealing with obesity or being overweight

Yes, if a woman becomes pregnant while on tirzepatide, it is generally advised to discontinue the medication immediately and consult a healthcare provider for alternative treatments

Semalgutide is a once a week subcutaneous injection given in the abdomen, thigh, or upper arm